These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6646877)

  • 21. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
    Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Doxycycline pharmacokinetics in chronic kidney failure patients treated by hemodialysis].
    Słuczanowski W
    Ann Acad Med Stetin; 1981; 27():313-30. PubMed ID: 7345952
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid pharmacokinetics in patients in chronic renal failure.
    Gold CH; Buchanan N; Tringham V; Viljoen M; Strickwold B; Moodley GP
    Clin Nephrol; 1976 Aug; 6(2):365-9. PubMed ID: 954244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
    Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis.
    Foote EF; Look ZM; Giles P; Keane WF; Halstenson CE
    Am J Kidney Dis; 1995 Mar; 25(3):420-5. PubMed ID: 7872319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of amikacin in subjects with normal renal function, in chronic renal failure and during hemodialysis].
    Oksenhendler G; Leroy A; Fillastre JP; Humbert G
    Nouv Presse Med; 1979 Oct; 8(42):3426-9. PubMed ID: 537888
    [No Abstract]   [Full Text] [Related]  

  • 28. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
    Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
    Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.
    Peterson LR; Bean B; Fasching CE; Korchik WP; Gerding DN
    Antimicrob Agents Chemother; 1981 Sep; 20(3):378-81. PubMed ID: 6458235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of moxalactam in patients with renal insufficiency.
    Lam M; Manion CV; Czerwinski AW
    Antimicrob Agents Chemother; 1981 Mar; 19(3):461-4. PubMed ID: 6454383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis].
    Gudim VI; Sigalla P; Ivanova VS; Oldag K
    Vopr Med Khim; 1980; 26(6):742-6. PubMed ID: 7456404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis of mefenamic acid in uremic patients.
    Wang LH; Lee CS; Marbury TC
    Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients.
    Keller E; Böhler J; Busse-Grawitz A; Reetze-Bonorden P; Krumme B; Schollmeyer P
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S20-3. PubMed ID: 7781200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cholestatic hepatic disease and chronic renal failure on alfentanil pharmacokinetics in children.
    Davis PJ; Stiller RL; Cook DR; Brandom BW; Davis JE; Scierka AM
    Anesth Analg; 1989 May; 68(5):579-83. PubMed ID: 2497657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
    Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
    Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.